M&A Deal Summary

Bausch Health Acquires Sanitas AB

On August 19, 2011, Bausch Health acquired life science company Sanitas AB

Acquisition Highlights
  • This is Bausch Health’s 10th transaction in the Life Science sector.
  • This is Bausch Health’s 1st transaction in Lithuania.

M&A Deal Summary

Date 2011-08-19
Target Sanitas AB
Sector Life Science
Buyer(s) Bausch Health
Deal Type Add-on Acquisition

Target

Sanitas AB

Kaunas, Lithuania
Sanitas AB is a branded generic pharmaceutical company focused on specialty therapeutic segments. Company are vertically integrated across formulation development, registration, manufacturing and sales and marketing.

Search 202,458 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada

Category Company
Sector Life Science
Employees20,270
Revenue 8.8B USD (2023)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.


DEAL STATS #
Overall 14 of 35
Sector (Life Science) 10 of 21
Type (Add-on Acquisition) 8 of 25
Country (Lithuania) 1 of 1
Year (2011) 6 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-15 Ortho Dermatologics

Skillman, New Jersey, United States

Ortho Dermatologics, Inc. is a provider of dermatologist recommended and prescribed skincare products RETIN-A MICRO, ERTACZO, and RENOVA.

Buy $345M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-20 iNova Pharmaceuticals

Singapore, Singapore

iNova Pharmaceuticals is a developer and marketer of over-the-counter and prescription medicines. iNova Pharmaceuticals was founded in 1958 and is based in Singapore.

Buy AU$700M